Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
E-pub ahead of print

β2-Adrenergic genotypes and risk of severe exacerbations in COPD: a prospective cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Midlife cardiorespiratory fitness and the long-term risk of chronic obstructive pulmonary disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Geographical variations in the use of cancer treatments are associated with survival of lung cancer patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Airflow limitation in people living with HIV and matched uninfected controls

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Safety of pulmonary function testing: data from 20 years

    Research output: Contribution to journalLetterResearchpeer-review

  1. Shared heritability and functional enrichment across six solid cancers

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Physical activity during pregnancy and intelligence in sons; A cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Prevalence and risk factors of prolonged QT interval and electrocardiographic abnormalities in persons living with HIV

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Individual susceptibility to exacerbations in chronic obstructive pulmonary disease (COPD) is likely influenced by genetic factors; however, most such variance is unexplained. We hypothesised that β2-adrenergic receptor genotypes, Gly16Arg (rs1042713, c.46G>A) and Gln27Glu (rs1042714, c.79C>G) influence risk of severe exacerbations in COPD.

METHODS: Among 96 762 individuals in the Copenhagen General Population Study, we identified 5262 with COPD (forced expiratory volume in one second divided by forced vital capacity, FEV1/FVC, below 0.7, FEV1 less than 80% of predicted value, age above 40 years and no asthma) who had genotyping performed. Severe exacerbations were defined as acute admissions due to COPD during 5 years of follow-up (mean 3.4 years). 923 individuals with COPD diagnosed similarly in the Copenhagen City Heart Study (CCHS) were used for replication analyses.

RESULTS: We recorded 461 severe exacerbations in 5262 subjects. The HRs for severe exacerbations were 1.62 (95% CI 1.30 to 2.03, p=0.00002) for 16Gly/Arg heterozygotes and 1.41 (1.04 to 1.91, p=0.03) for 16Arg homozygotes, compared with 16Gly homozygotes. HRs were 1.35 (1.03 to 1.76, p=0.03) for 27Gln/Glu heterozygotes and 1.49 (1.12 to 1.98, p=0.006) for 27Gln homozygotes, compared with 27Glu homozygotes. Similar trends were observed in the CCHS. Among 27Gln homozygotes only, HRs were 5.20 (1.81 to 14.9, p=0.002) for 16Gly/Arg heterozygotes and 4.03 (1.40 to 11.6, p=0.01) for 16Arg homozygotes, compared with 16Gly homozygotes.

CONCLUSION: Common β2-adrenergic receptor genotypes influence risk of severe exacerbations in COPD, potentially mainly by genetic influence of the 16Arg allele in rs1042713.

Original languageEnglish
JournalThorax
ISSN0040-6376
DOIs
Publication statusE-pub ahead of print - 3 Sep 2019

ID: 57916651